About Abramson Cancer Center at Pennsylvania Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Abramson Cancer Center at Pennsylvania Hospital
During the past decade, Abramson Cancer Center at Pennsylvania Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age
2007-10-01
2009-04-01
Terminated
30
Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back
2008-04-01
2009-03-01
Completed
830
A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval
2015-04-01
2020-03-16
Completed
2,404
Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use
2016-10-25
2018-01-22
Completed
346
Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)
2018-10-30
2019-11-16
Terminated
51
A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
2019-09-18
2025-12-17
Recruiting
288
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Abramson Cancer Center at Pennsylvania Hospital" #1 sponsor was "Radiation Therapy Oncology Group" with 2 trials, followed by "Amgen" with 1 trials
sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Peel Therapeutics Inc" with 1 trials sponsored and "Rain Oncology Inc"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Abramson Cancer Center at Pennsylvania Hospital"
#1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Abramson Cancer Center at Pennsylvania Hospital
According to Clinical.Site data, the most researched conditions in "Abramson Cancer Center at Pennsylvania Hospital" are
"Prostate Cancer" (2 trials), "Advanced Solid Tumor" (1 trials), "Aggressive Fibromatosis" (1 trials), "Dedifferentiated Liposarcoma" (1 trials) and "Desmoid Tumor" (1 trials). Many other conditions were trialed in "Abramson Cancer Center at Pennsylvania Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Abramson Cancer Center at Pennsylvania Hospital
Most popular intervention types in "Abramson Cancer Center at Pennsylvania Hospital" are "Drug" (6 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "70.2 Gy 3D-CRT/IMRT" (1 trials), "79.2 Gy 3D-CRT/IMRT" (1 trials), "Cabozantinib" (1 trials), "Conventional 3D-CRT or IMRT" (1 trials) and "Denosumab (Cohort A)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Abramson Cancer Center at Pennsylvania Hospital
The vast majority of trials in "Abramson Cancer Center at Pennsylvania Hospital" are
6 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Abramson Cancer Center at Pennsylvania Hospital
Currently, there are NaN active trials in "Abramson Cancer Center at Pennsylvania Hospital".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Abramson Cancer Center at Pennsylvania Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Abramson Cancer Center at Pennsylvania Hospital, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".